Olema Pharmaceuticals, Inc. (OLMA)

Last Year

30-Apr-23 -- 29-Apr-24

Time Period:

($124.70K) Net Amount

Buy:	0	--
Sell:	($124.70K)	$6.05 - $6.30

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

1

(2)

1

(1)

8

0

5

+1

0

+2

0

+3

Two Year Chart

30-Apr-22 -- 29-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
16-Jan-24 7:30 AM View:	12-Jan-24 Option Exercise $351.00K	Kovacs Shane William Charles Ch. Operating & Financial Off.		Olema Pharmaceuticals, Inc. - OLMA	19% 406.98K to 484.99K	0	0	--	--	Show Txns Hide Txns

06-Mar-24 10:00 PM View:	05-Mar-24 Disposition (other) 0	Rappaport Andrew Director		Olema Pharmaceuticals, Inc. - OLMA	(20%) 481.01K to 385.96K	0	0	--	--	Show Txns Hide Txns

22-Nov-23 7:00 PM View:	22-Nov-23 Sale ($388.26K)	Bohen Sean President and CEO Director		Olema Pharmaceuticals, Inc. - OLMA	58% 91.9K to 144.93K	0	0	--	--	Show Txns Hide Txns

18-Dec-23 6:30 PM View:	05-Dec-23 Purchase $1.87M	Graham G. Walmsley Director		Olema Pharmaceuticals, Inc. - OLMA	17% 3.74M to 4.38M	0	0	--	--	Show Txns Hide Txns

14-Sep-23 4:25 PM View:	14-Sep-23 Acquisition (other) 0	Bvf Partners L P/il Director 10% Owner		Olema Pharmaceuticals, Inc. - OLMA	22% 7.29M to 8.9M	0	0	--	--	Show Txns Hide Txns

20-Mar-24 5:30 PM View:	18-Mar-24 Option Exercise $66.72K	Zojwalla Naseem CHIEF MEDICAL OFFICER		Olema Pharmaceuticals, Inc. - OLMA	367% 17.22K to 80.36K	0	0	--	--	Show Txns Hide Txns

29-Mar-24 5:00 PM View:	28-Mar-24 Private Sale (Planned) ($219.40K)	Harmon Cyrus Director		Olema Pharmaceuticals, Inc. - OLMA	(20%) 1.18M to 948.31K	0	($124.70K) (2%)	--	$6.05 - $6.30	Show Txns Hide Txns

08-Dec-23 4:19 PM View:	06-Dec-23 Purchase $1.16M	Paradigm Biocapital Advisor... 10% Owner		Olema Pharmaceuticals, Inc. - OLMA	1% 7.8M to 7.9M	0	0	--	--	Show Txns Hide Txns

22-Nov-23 7:00 PM View:	22-Nov-23 Sale ($92.41K)	Myles David C. CH. DISCOV. & NON-CLIN DEV OFF		Olema Pharmaceuticals, Inc. - OLMA	(2%) 759.69K to 741.78K	0	0	--	--	Show Txns Hide Txns